(Q35102590)
Statements
1 reference
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286. (English)
1 reference
Babafemi Taiwo
1 reference
David M Margolis
1 reference
Allan R Tenorio
1 reference
Ellen S Chan
1 reference
Ronald J Bosch
1 reference
Bernard J C Macatangay
1 reference
Sarah W Read
1 reference
Suria Yesmin
1 reference
Jeffrey M Jacobson
1 reference
Alan L Landay
1 reference
Cara C Wilson
1 reference
A5286 Team
1 reference
11 September 2014
1 reference
1 reference
211
1 reference
5
1 reference
780-790
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference